Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 11 07 2019
accepted: 23 01 2020
pubmed: 29 1 2020
medline: 27 1 2021
entrez: 29 1 2020
Statut: ppublish

Résumé

Systemic sclerosis (SSc) is an autoimmune fibrotic disease whose pathogenesis is poorly understood and lacks effective therapies. We undertook quantitative analyses of T cell infiltrates in the skin of 35 untreated patients with early diffuse SSc and here show that CD4+ cytotoxic T cells and CD8+ T cells contribute prominently to these infiltrates. We also observed an accumulation of apoptotic cells in SSc tissues, suggesting that recurring cell death may contribute to tissue damage and remodeling in this fibrotic disease. HLA-DR-expressing endothelial cells were frequent targets of apoptosis in SSc, consistent with the prominent vasculopathy seen in patients with this disease. A circulating effector population of cytotoxic CD4+ T cells, which exhibited signatures of enhanced metabolic activity, was clonally expanded in patients with systemic sclerosis. These data suggest that cytotoxic T cells may induce the apoptotic death of endothelial and other cells in systemic sclerosis. Cell loss driven by immune cells may be followed by overly exuberant tissue repair processes that lead to fibrosis and tissue dysfunction.

Identifiants

pubmed: 31990684
pii: 131700
doi: 10.1172/JCI131700
pmc: PMC7190971
doi:
pii:

Substances chimiques

HLA-DR Antigens 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2451-2464

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI110495
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States
Organisme : NIAMS NIH HHS
ID : K24 AR063120
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI110498
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR070470
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144298
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Dis Markers. 2011;31(6):337-42
pubmed: 22182806
Arthritis Rheumatol. 2018 Mar;70(3):450-461
pubmed: 29193892
Arthritis Rheumatol. 2016 Oct;68(10):2540-9
pubmed: 27159521
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Ann Rheum Dis. 2019 Jul;78(7):979-987
pubmed: 30967395
Front Immunol. 2013 Sep 06;4:266
pubmed: 24046769
Arthritis Rheum. 2009 Apr;60(4):1119-28
pubmed: 19333920
Science. 2017 Jun 9;356(6342):1072-1076
pubmed: 28495875
Ann Rheum Dis. 2008 Jan;67(1):98-104
pubmed: 17526554
N Engl J Med. 2018 Jan 4;378(1):35-47
pubmed: 29298160
Arthritis Rheumatol. 2018 Jul;70(7):1133-1143
pubmed: 29499100
Arthritis Rheum. 2006 Jul;54(7):2250-62
pubmed: 16802364
Ann Rheum Dis. 2016 Aug;75(8):1567-73
pubmed: 26371289
J Allergy Clin Immunol. 2016 Sep;138(3):825-838
pubmed: 26971690
Autoimmunity. 2015;48(7):429-33
pubmed: 26057401
Rheumatology (Oxford). 2018 Dec 1;57(12):2106-2113
pubmed: 30053212
Sci Rep. 2016 Jan 18;6:19227
pubmed: 26778409
Arthritis Rheum. 2002 Feb;46(2):445-50
pubmed: 11840447
J Exp Med. 1989 Sep 1;170(3):763-75
pubmed: 2475573
Cytometry A. 2004 Jun;59(2):182-90
pubmed: 15170597
Sci Rep. 2018 Feb 23;8(1):3529
pubmed: 29476109
Nat Commun. 2017 Nov 13;8(1):1473
pubmed: 29133794
J Leukoc Biol. 1997 May;61(5):539-44
pubmed: 9129201
Arch Dermatol. 1996 Jul;132(7):802-6
pubmed: 8678573
Autoimmun Rev. 2018 Mar;17(3):244-255
pubmed: 29343447
Immunol Rev. 2009 May;229(1):5-11
pubmed: 19426211
N Engl J Med. 2018 May 10;378(19):1811-1823
pubmed: 29742380
Ann Rheum Dis. 2015 Jun;74(6):1171-7
pubmed: 25667206
Front Immunol. 2017 Jan 23;8:19
pubmed: 28167943
PLoS One. 2010 Jan 29;5(1):e8959
pubmed: 20126467
Sci Transl Med. 2018 Mar 7;10(431):
pubmed: 29514998
Arch Dermatol Res. 2004 Oct;296(5):235-9
pubmed: 15452726
Front Immunol. 2013 Dec 23;4:456
pubmed: 24391640
Semin Immunopathol. 2015 Sep;37(5):489-500
pubmed: 26152638
Nat Commun. 2018 Jul 26;9(1):2937
pubmed: 30050112
Br J Haematol. 2002 Dec;119(3):726-39
pubmed: 12437652
J Invest Dermatol. 2018 Sep;138(9):1917-1924
pubmed: 29588155
Sci Transl Med. 2018 Oct 17;10(463):
pubmed: 30333237
J Rheumatol. 2017 Aug;44(8):1190-1197
pubmed: 28507177
Am J Pathol. 1997 Dec;151(6):1751-8
pubmed: 9403725
Lancet. 2011 Aug 6;378(9790):498-506
pubmed: 21777972
Autoimmun Rev. 2017 Aug;16(8):774-786
pubmed: 28572048
PLoS One. 2009 Jun 17;4(6):e5903
pubmed: 19536281
Nat Protoc. 2016 Sep;11(9):1599-616
pubmed: 27490633
J Rheumatol. 2010 Oct;37(10):2053-63
pubmed: 20716660
Arthritis Res Ther. 2011;13(5):R166
pubmed: 21996293
Arthritis Rheum. 2006 Nov;54(11):3655-60
pubmed: 17075814
Lancet. 2015 Apr 11;385(9976):1460-71
pubmed: 25481618
Chest. 2017 Nov;152(5):999-1007
pubmed: 28629914
Arch Dermatol Res. 2005 May;296(11):509-13
pubmed: 15803328
Ann Rheum Dis. 2017 Feb;76(2):377-385
pubmed: 27358392
J Clin Invest. 1996 Aug 1;98(3):785-92
pubmed: 8698871
J Pathol. 1992 Mar;166(3):255-63
pubmed: 1517881
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63
pubmed: 26195744
Expert Rev Vaccines. 2010 Dec;9(12):1453-63
pubmed: 21105780
Sci Immunol. 2018 Jan 19;3(19):
pubmed: 29352091
Arthritis Rheum. 2003 Sep;48(9):2605-14
pubmed: 13130480
Arthritis Res Ther. 2013 Oct 10;15(5):R151
pubmed: 24289089
J Allergy Clin Immunol. 2015 Apr;135(4):946-.e9
pubmed: 25678090
Gigascience. 2018 Jun 1;7(6):
pubmed: 29846586
J Immunol. 2015 Aug 1;195(3):892-900
pubmed: 26109642

Auteurs

Takashi Maehara (T)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Naoki Kaneko (N)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.

Cory A Perugino (CA)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Hamid Mattoo (H)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Immunology and Inflammation Therapeutic Area, Sanofi, Cambridge Massachusetts, USA.

Jesper Kers (J)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Amsterdam Infection & Immunity Institute (AI&II) and.
Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, and.
Van 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, Netherlands.

Hugues Allard-Chamard (H)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Division of Rheumatology, Faculté de médecine et des sciences de la santé, Université de Sherbrooke et Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke, Québec, Canada.

Vinay S Mahajan (VS)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Hang Liu (H)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
Department of Rheumatology and Immunology, First Affiliated Hospital of China, Shenyang, China.

Samuel Jh Murphy (SJ)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.

Musie Ghebremichael (M)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.

David Fox (D)

Division of Rheumatology, Medical School, University of Michigan, Ann Arbor, Michigan, USA.

Aimee S Payne (AS)

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Robert Lafyatis (R)

Division of Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

John H Stone (JH)

Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Dinesh Khanna (D)

Division of Rheumatology, Medical School, University of Michigan, Ann Arbor, Michigan, USA.

Shiv Pillai (S)

Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH